Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
2021
2020
Europe
Clear all
Type of publications
NITAG documentation
(90)
Scientific publications
(1)
Systematic reviews (SYSVAC)
(2)
Topics
Available to download in languages
Regions
Europe
(93)
Africa
(18)
Americas
(126)
South-East Asia
(5)
Western Pacific
(34)
Countries
Belgium
(16)
Denmark
(2)
France
(20)
Germany
(8)
Ireland
(7)
Netherlands
(7)
Spain
(1)
Sweden
(3)
United Kingdom
(27)
Diseases
COVID-19
(93)
Ebola
(3)
Hepatitis B
(1)
Human papillomavirus (HPV)
(6)
Influenza
(9)
Measles
(1)
Pneumococcal disease
(3)
Rotavirus
(1)
Tuberculosis
(1)
Typhoid
(1)
Varicella
(2)
Yellow fever
(1)
Vaccine topics
Acceptance
(1)
Coverage
(2)
Ethical issues
(1)
Target population
Adolescents
(1)
Adults
(2)
All age groups
(1)
Healthcare workers
(1)
Older adults
(2)
Pregnant women
(1)
Risk group
(2)
Publication date
2021
(76)
2020
(17)
2024
(3)
2023
(15)
2022
(35)
2019
(4)
2018
(4)
2012
(1)
2010
(1)
93 results found
2021
∙
Conseil Supérieur de la Santé (CSS)
Recommendations regarding the pediatric vaccination against SARS-CoV-2 of children aged older than 12 in Belgium - 9 July 2021
2021
∙
Conseil Supérieur de la Santé (CSS)
SARS-CoV-2 vaccination recommendations for people aged 16 to 17 (part 1) in Belgium - 20 May 2021
2021
∙
Conseil Supérieur de la Santé (CSS)
Seasonal influenza vaccination: winter season 2021-2022 (in the context of Covid-19, Belgium) - 10 June 2021
2021
∙
STIKO
STIKO resolution on the 14th update of the COVID-19 vaccination recommendation
2021
∙
STIKO
STIKO resolution on the 8th update of the COVID-19 vaccination recommendation and the associated scientific justification - 8 July 2021
2021
∙
STIKO
STIKO statement on the time of administration of an mRNA vaccine after first vaccination with AstraZeneca Vaccine (Vaxzevria) in <60-year-olds - 14 April, 2021
2021
∙
Haute Autorité de Santé
Update of risk factors for severe forms of Covid-19 and recommendations on the strategy for prioritizing populations to be vaccinated
2021
∙
JCVI
Update to JCVI advice on booster vaccination in adults
2021
∙
NIAC
Updated recommendations regarding selection, dose and timing of booster doses of COVID-19 vaccine for those aged 60 years and over
2021
∙
JCVI
Use of the AstraZeneca COVID-19 (AZD1222) vaccine: updated JCVI statement, 7 May 2021
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register